Abstract:Pyruvate kinase M2 (PKM2), as the terminal and last rate-limiting enzyme of the glycolytic pathway, is an ideal enzyme for regulating metabolic phenotype. PKM2 tetramer activation has shown a protective role against diabetic kidney disease (DKD). However, the molecular mechanisms involved in diabetic tubular have not been investigated so far. In this study, we performed transcriptome gene expression profiling in human renal proximal tubular epithelial cell line (HK-2 cells) treated with 25 mM high D-glucose (HG) for 7 days before the addition of 10 μM TEPP-46, an activator of PKM2 tetramerization, for a further 1 day in the presence of HG. Afterwards, we analyzed the differentially expressed (DE) genes and investigated gene relationships based on weighted gene co-expression network analysis. The results showed that 2,902 DE genes were identified (adjusted P -value ≤ 0.05), where 2,509 DE genes (86.46%) were co-expressed in the key module. Four extremely downregulated DE genes ( HSPA8 , HSPA2 , HSPA1B , and ARRB1 ) and three extremely upregulated DE genes ( GADD45A , IGFBP3 , and SIAH1 ) enriched in the downregulated endocytosis (hsa04144) and upregulated p53 signaling pathway (hsa04115), respectively, were validated by qRT-PCR experiments. The qRT-PCR results showed that the relative expression levels of HSPA8 [adjusted P -value = 4.45 × 10 -34 and log 2 (FC) = -1.12], HSPA2 [adjusted P -value = 6.09 × 10 -14 and log 2 (FC) = -1.27], HSPA1B [adjusted P -value = 1.14 × 10 -11 and log 2 (FC) = -1.02], and ARRB1 [adjusted P -value = 2.60 × 10 -5 and log 2 (FC) = -1.13] were significantly different ( P -value < 0.05) from the case group to the control group. Furthermore, the interactions and predicted microRNAs of the key genes ( HSPA8 , HSPA2 , HSPA1B , and ARRB1 ) were visualized in networks. This study identified the key candidate transcriptomic biomarkers and biological pathways in hyperglycemic HK-2 cells responding to the PKM2 activator TEPP-46 that can highlight a possibility of PKM2 tetramerization reshaping the interplay among endocytic trafficking through the versatile networks of Hsp70s and rewiring the crosstalk between EGFR signal transduction circuits and metabolic stress to promote resilience, which will be valuable for further research on PKM2 in DKD.

A High-Throughput Targeted Proteomic Approach for Comprehensive Profiling of Methylglyoxal-Induced Perturbations of the Human Kinome.

A Targeted Quantitative Proteomics Strategy for Global Kinome Profiling of Cancer Cells and Tissues

Quantitative Chemoproteomic Profiling of Protein Cross-Links Induced by Methylglyoxal.

Proteomic identification of aerobic glycolysis as a potential metabolic target for methylglyoxal in adipocytes

Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells

A Non-Targeted Capillary Electrophoresis-Mass Spectrometry Strategy to Study Metabolic Differences in an In Vitro Model of High-Glucose Induced Changes in Human Proximal Tubular HK-2 Cells

Proteomic Approach to Substrates Related to MAPK Pathway in 293T Cells

Proteomic analysis of diabetic retinas

Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

Transcriptome Analysis Reveal Candidate Genes and Pathways Responses to Lactate Dehydrogenase Inhibition (Oxamate) in Hyperglycemic Human Renal Proximal Epithelial Tubular Cells

Site-specific Chemoproteomic Profiling of Targets of Glyoxal

Visualization Of Methylglyoxal In Living Cells And Diabetic Mice Model With A 1,8-Naphthalimide-Based Two-Photon Fluorescent Probe

Expression Profile Of Mitrogen-Activated Protein Kinase (Mapk) Signaling Genes In The Skeletal Muscle & Liver Of Rat With Type 2 Diabetes: Role In Disease Pathology

473-P: Identification of Novel Genes Participating in Diabetic Macrovascular Complications by DNA Methylation Modulation

Methylglyoxal:a new therapeutic target for diabetic complications

Molecular mechanism of ectopic lipid accumulation induced by methylglyoxal via activation of the NRF2/PI3K/AKT pathway implicates renal lipotoxicity caused by diabetes mellitus

Targeted Proteomic Approaches for Proteome-Wide Characterizations of the AMP-Binding Capacities of Kinases.

Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease

Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal.

Parallel phosphoproteomics and metabolomics map the global metabolic tyrosine phosphoproteome

Multiplexed Quantitative MALDI MS Approach for Assessing Activity and Inhibition of Protein Kinases Based on Postenrichment Dephosphorylation of Phosphopeptides by Metal-Organic Framework-Templated Porous CeO2.